...
首页> 外文期刊>Cureus. >Preoperative Ultrasound-guided Core Biopsy of Axillary Nodes for Staging of Clinically Negative Axilla in Breast Cancer Patients – A Pilot Study
【24h】

Preoperative Ultrasound-guided Core Biopsy of Axillary Nodes for Staging of Clinically Negative Axilla in Breast Cancer Patients – A Pilot Study

机译:术前超声引导的疾病节点的核心活检,用于乳腺癌患者临床阴性腋窝的分期 - 试点研究

获取原文

摘要

Objective The aim of the current study is to determine the feasibility and accuracy of ultrasound-guided core biopsy for staging the axilla in clinically node-negative?patients with invasive breast cancer. Introduction Historically, in breast cancer patients, axillary lymph node dissection was performed to stage axilla. Because of the high morbidity of axillary lymph node dissection, sentinel lymph node biopsy (SLNB) became the standard of care in patients with clinically node-negative breast cancer. However, SLNB?is expensive, time consuming, can cause morbidity and can be complicated by seroma formation, sensory nerve injury, lymphedema, etc.?Many centers rely on the availability of frozen section on sentinel lymph nodes to avoid a second procedure with the?accuracy of procedure ranging from 73 to 96%, however, the availability?of frozen section is limited in our part of the world.?Pre-operative identification of axillary node positivity in patients with clinically negative nodes by ultrasound imaging of the axilla?would allow one-stage axillary clearance and can decrease the need for SLNB?from 21% to 70%. The aim of the present study is to determine the accuracy and feasibility of ultrasound-guided core biopsy to stage the axilla in clinically node-negative breast cancer patients, comparing with final histopathology as gold standard. Material & methods This was a non-randomized, prospective interventional study, done at Radiology Department of Aga Khan University Hospital. All?patients?diagnosed with breast cancer (histologically proven) with clinically negative axilla and ipsilateral positive axillary ultrasound were included. These patients underwent?axillary lymph node core biopsy. If the result was negative they were subjected to SLNB. Histopathology result?was taken?as gold standard. Results The sensitivity of ultrasound-guided core biopsy was 88%, specificity 100%, positive predictive values (PPV) 100%, negative predictive values (NPV) 89.28%, diagnostic accuracy 94%. Conclusion In conclusion, the present study demonstrated high accuracy of ultrasound-guided axillary lymph node core biopsy in breast cancer?patients with clinically node-negative axilla. Positive core biopsy results can thus obviate the need for sentinel lymph node biopsy and allow?breast surgeons?to directly proceed to axillary lymph node dissection.
机译:目的目的的目的是确定超声引导核心活检的可行性和准确性,用于在临床节点阴性中暂存腋窝癌症?患有侵袭性乳腺癌的患者。历史上介绍,在乳腺癌患者中,对腋下进行腋窝淋巴结解剖。由于腋窝淋巴结清扫的发病率高,Sentinel淋巴结活检(SLNB)成为临床节点阴性乳腺癌患者的护理标准。但是,SLNB?昂贵,耗时,可引起发病率,可通过血清瘤形成,感觉神经损伤,淋巴水肿等复杂,依赖于Sentinel淋巴结的冷冻部分的可用性,以避免第二个程序吗?步骤的准确性范围从73到96%,但是冻结部分的可用性在我们的一部分是有限的.?通过腋窝的超声成像在临床阴性节点患者中鉴定腋窝节点阳性的鉴定术。将允许单级腋窝间隙,并可降低SLNB的需求?21%至70%。本研究的目的是确定超声引导的核心活组织检查在临床节点阴性乳腺癌患者中逐步阶段的准确性和可行性,与最终组织病理学为金标准。材料和方法这是在Aga Khan大学医院放射科的非随机性前瞻性介入研究。所有?患者?患有临床阴性腋窝和同侧阳性腋窝超声的乳腺癌(组织学证明)。这些患者接受了α腋窝淋巴结核心活组织检查。如果结果是阴性,则会对SLNB进行。组织病理学结果?被拍了?作为金标准。结果超声引导核心活检的灵敏度为88%,特异性100%,阳性预测值(PPV)100%,负预测值(NPV)89.28%,诊断准确性为94%。结论总之,本研究表明,乳腺癌中超声引导的腋窝淋巴结核心活组织检查的高精度?临床节点阴性腋窝。因此,阳性核心活组织检查结果可以避免患塞蛋白淋巴结活检并允许?乳房外科医生?直接进入腋窝淋巴结解剖。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号